Atlas Trials

Relapsed or Refractory Indolent Non-Hodgkin Lymphoma

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Relapsed or Refractory Indolent Non-Hodgkin Lymphoma

RecordFirmDate
A Study to Learn More About Copanlisib Treatment Patterns in People With Indolent Non-Hodgkin Lymphoma, a Type of Cancer That Grows and Spread Slowly and Develops in the Lymphatic System (a Part of Immune System) in Taiwan Under Real-word Conditions (NCT05217914)Bayer2022-07-01

Track Relapsed or Refractory Indolent Non-Hodgkin Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.